Enact Holdings Insider Sells Shares as FTC Clears Deal
Snack-Sized Version:
A recent Enact Holdings insider sale has caught investor attention, with a director selling shares worth $373,954 on November 20, 2025. This transaction comes just after the Federal Trade Commission (FTC) approved a final consent order related to the ACT-Giant Eagle deal on November 19. Meanwhile, income investors are looking ahead to the dividend payment following the November 21 ex-dividend date. These developments highlight a busy week for Enact Holdings Inc.
| Market Activity: At a Glance | |
|---|---|
| Recent Insider Activity | Director sold ~$374k in stock on Nov 20, 2025. |
| Regulatory Update | FTC approved consent order on Nov 19, 2025. |
| Dividend Context | Ex-dividend date was Nov 21, 2025. |
| Payment Date | Dividend payable Dec 11, 2025. |
| Stock Trend | Trading near recent highs. |
Source: SEC filings; company news.
Read the Full Meal:
Enact Holdings Inc (NASDAQ:ACT) has seen notable activity this week, starting with a significant regulatory milestone. On November 19, the FTC approved a final consent order involving the company, clearing a path forward. Following this, a company director executed a stock sale valued at nearly $374,000, a move often scrutinized for sentiment signals. Amidst these events, the company passed its ex-dividend date on November 21, locking in the $0.21 per share payment for eligible shareholders. You can follow more updates at the Enact Holdings Inc News Hub.
Regulatory and Insider Developments
- Capital allocation: The confirmed dividend payment demonstrates continued commitment to returning cash to shareholders.
- Regulatory landscape: The FTC consent order resolution removes a layer of uncertainty regarding the specific deal.
- Insider sentiment: While the director’s sale is substantial, it may reflect personal portfolio management rather than a negative outlook.
- Risks: Mortgage insurance remains sensitive to housing market fluctuations and interest rate shifts.
Quick links
- Sources: Enact Newsroom.
- IR hub: SEC filings
Why this can matter for ACT holders
- Continuity: Regular dividends and regulatory clearance suggest business as usual despite the insider sale.
- Cycle timing: Clearing regulatory hurdles positions the company to focus on core operations in the coming year.
- Multiple support: Clarity on legal matters often helps remove valuation discounts applied by the market.
What to watch next
- Official filing: Review the Form 4 for the director’s sale to see the remaining stake.
- Next event: Dividend payment scheduled for December 11, 2025.
- Board, governance, or roadmap: Watch for any further regulatory updates or strategic shifts following the FTC order.
Mini FAQ
What was the insider activity?
A director sold approximately $374,000 worth of stock.
Did the FTC block the deal?
No, the FTC approved a final consent order, allowing the matter to proceed under conditions.